NCT01736592: An ongoing trial by Sanofi
This trial is ongoing. It must report results 10 years, 4 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT01736592 |
|---|---|
| Title | An Open Label Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Dec. 14, 2012 |
| Completion date | Aug. 29, 2033 |
| Required reporting date | Aug. 29, 2034, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | None |